Legacy Effects of Baseline Blood Pressure 'Treatment Naivety' on All-cause and Cardiovascular Mortality in the Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

被引：0
|
作者：
Ho, Chau
Bresliln, Monique
Chowdhury, Enayet
Doust, Jenny
Reid, Christopher M.
Davis, Barry R.
Simpson, Lara M.
Nelson, Mark R.
机构：
来源：
CIRCULATION | 2019年 / 140卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A11020
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Lack of a significant legacy effect of baseline blood pressure 'treatment naivety' on all-cause and cardiovascular mortality in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    Ho, Chau L. B.
    Breslin, Monique
    Chowdhury, Enayet K.
    Doust, Jenny
    Reid, Christopher M.
    Davis, Barry R.
    Simpson, Lara M.
    Nelson, Mark R.
    JOURNAL OF HYPERTENSION, 2020, 38 (03) : 519 - 526
  • [2] Blood pressure control in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Cushman, WC
    Ford, CE
    Cutler, JA
    Margolis, KL
    Davis, BR
    Grimm, RH
    CIRCULATION, 2002, 106 (19) : 476 - 476
  • [3] Angioedema in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Piller, L
    Ford, C
    Davis, B
    Nwachuku, C
    Black, H
    Oparil, S
    Gappy, S
    Retta, T
    Probstfield, J
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 92A - 92A
  • [4] Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Barzilay, JI
    Jones, CL
    Davis, BR
    Basile, JN
    Goff, DC
    Ciocon, JO
    Sweeney, ME
    Randall, OS
    DIABETES CARE, 2001, 24 (04) : 654 - 658
  • [5] Blood Pressure Control by Drug Group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Cushman, William C.
    Ford, Charles E.
    Einhorn, Paula T.
    Wright, Jackson T., Jr.
    Preston, Richard A.
    Davis, Barry R.
    Basile, Jan N.
    Whelton, Paul K.
    Weiss, Robert J.
    Bastien, Arnaud
    Courtney, Donald L.
    Hamilton, Bruce P.
    Kirchner, Kent
    Louis, Gail T.
    Retta, Tamrat M.
    Vidt, Donald G.
    JOURNAL OF CLINICAL HYPERTENSION, 2008, 10 (10): : 751 - 760
  • [6] Mortality and morbidity during and after the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Probstfield, J. L.
    Cushman, W. C.
    Davis, B. R.
    Pressel, S.
    Cutler, J. A.
    Einhorn, P.
    Ford, C.
    Oparil, S.
    Whelton, P.
    Wright, J. T.
    EUROPEAN HEART JOURNAL, 2010, 31 : 321 - 321
  • [7] Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) - Practical implications
    Oparil, S
    HYPERTENSION, 2003, 41 (05) : 1006 - 1009
  • [8] Antihypertensive and lipid-lowering treatment to prevent heart attack (ALLHAT) trial: Interim results
    Davis, B
    Furberg, CD
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (01) : 325 - 325
  • [9] Participant recruitment in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Pressel, S
    Davis, BR
    Louis, GT
    Whelton, P
    Adrogue, H
    Egan, D
    Farber, M
    Payne, G
    Probstfield, J
    Ward, H
    CONTROLLED CLINICAL TRIALS, 2001, 22 (06): : 674 - 686
  • [10] Baseline characteristics of participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Grimm, RH
    Margolis, KL
    Papademetriou, V
    Cushman, WC
    Ford, CE
    Bettencourt, J
    Alderman, MH
    Basile, JN
    Black, HR
    DeQuattro, V
    Eckfeldt, J
    Hawkins, CM
    Perry, HM
    Proschan, M
    HYPERTENSION, 2001, 37 (01) : 19 - 27
12345